Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severity score indexes for blistering diseases.

Literature DB >> 22137234

Severity score indexes for blistering diseases.

Benjamin S Daniel¹, Michael Hertl, Victoria P Werth, Rüdiger Eming, Dédée F Murrell.

Abstract

Scoring systems are used to assess the severity of a disease and the response to treatment. The main severity scoring indexes are the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and the Pemphigus Disease Area Index (PDAI). They have been validated and are already used in the evaluation of pemphigus and in clinical trials. They quantify disease severity by performing a global assessment of all lesions. In recent years, other severity scoring systems have been developed for pemphigus and other autoimmune blistering diseases.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2012 PMID： 22137234 PMCID： PMC3928011 DOI： 10.1016/j.clindermatol.2011.03.017

Source DB: PubMed Journal: Clin Dermatol ISSN： 0738-081X Impact factor: 3.541

26 in total

1. A new grading system for oral pemphigus.

Authors: Abir Saraswat; Kumar Bhushan; Chandigarh India
Journal: Int J Dermatol Date: 2003-05 Impact factor: 2.736

2. Cicatricial pemphigoid.

Authors: C S Foster
Journal: Trans Am Ophthalmol Soc Date: 1986

3. Correlation of immunological profile with phenotype and disease outcome in pemphigus.

Authors: Josep E Herrero-González; Pilar Iranzo; Daniel Benítez; Francisco Lozano; Carmen Herrero; José M Mascaró
Journal: Acta Derm Venereol Date: 2010-07 Impact factor: 4.437

4. Ocular cicatricial pemphigoid.

Authors: B J Mondino; S I Brown
Journal: Ophthalmology Date: 1981-02 Impact factor: 12.079

5. The correlation of disease activity and antibody titers in pemphigus.

Authors: R E Fitzpatrick; V D Newcomer
Journal: Arch Dermatol Date: 1980-03

6. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.

Authors: K E Harman; P T Seed; M J Gratian; B S Bhogal; S J Challacombe; M M Black
Journal: Br J Dermatol Date: 2001-04 Impact factor: 9.302

7. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).

Authors: Andrea Niedermeier; Rüdiger Eming; Martin Pfütze; Christine R Neumann; Claudia Happel; Kristian Reich; Michael Hertl
Journal: Arch Dermatol Date: 2007-02

Review 8. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.

Authors: Martin Pfütze; Andrea Niedermeier; Michael Hertl; Rüdiger Eming
Journal: Eur J Dermatol Date: 2007-02-27 Impact factor: 3.328

9. The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire.

Authors: S Tabolli; A Mozzetta; V Antinone; S Alfani; G Cianchini; D Abeni
Journal: Br J Dermatol Date: 2008-02-22 Impact factor: 9.302

10. Pemphigus: active or inactive?

Authors: Jignesh B Vaishnani; Sanjay S Bosamiya
Journal: Indian J Dermatol Date: 2009 Impact factor: 1.494

18 in total

1. Evaluation of exposure of pemphigus vulgaris patients to Mycobacterium tuberculosis and Aspergillus fumigatus.

Authors: R A Ali; R H Elsherif; M A Saleh; M H Ismail
Journal: Eur J Clin Microbiol Infect Dis Date: 2016-07-11 Impact factor: 3.267

2. Guidelines on the use of extracorporeal photopheresis.

Authors: R Knobler; G Berlin; P Calzavara-Pinton; H Greinix; P Jaksch; L Laroche; J Ludvigsson; P Quaglino; W Reinisch; J Scarisbrick; T Schwarz; P Wolf; P Arenberger; C Assaf; M Bagot; M Barr; A Bohbot; L Bruckner-Tuderman; B Dreno; A Enk; L French; R Gniadecki; H Gollnick; M Hertl; C Jantschitsch; A Jung; U Just; C-D Klemke; U Lippert; T Luger; E Papadavid; H Pehamberger; A Ranki; R Stadler; W Sterry; I H Wolf; M Worm; J Zic; C C Zouboulis; U Hillen
Journal: J Eur Acad Dermatol Venereol Date: 2014-01 Impact factor: 6.166

3. From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.

Authors: Ralf J Ludwig; Luca Borradori; Luis A Diaz; Takashi Hashimoto; Michael Hertl; Saleh M Ibrahim; Marcel F Jonkman; Yasuo Kitajima; Dédée F Murrell; Enno Schmidt; Hiroshi Shimizu; John R Stanley; David T Woodley; Detlef Zillikens
Journal: J Invest Dermatol Date: 2014-09 Impact factor: 8.551

Review 4. Extracorporeal photopheresis as a therapy for autoimmune diseases.

Authors: Zoya Kuzmina; David Stroncek; Steven Z Pavletic
Journal: J Clin Apher Date: 2014-12-26 Impact factor: 2.821

5. Quality of Life Assessment in Korean Patients with Pemphigus.

Authors: Jae Yong Sung; Mi Ryung Roh; Soo-Chan Kim
Journal: Ann Dermatol Date: 2015-10-02 Impact factor: 1.444

6. Evaluation of prolactin levels in patients with newly diagnosed pemphigus vulgaris and its correlation with pemphigus disease area index.

Authors: Vahideh Lajevardi; Zahra Hallaji; Maryam Daneshpazhooh; Narges Ghandi; Peyman Shekari; Sepideh Khani
Journal: Int J Womens Dermatol Date: 2016-04-23